Full text is available at the source.
Abstract
Propionate is consistently associated with a protective effect on multiple sclerosis outcomes.
- Short-chain fatty acids (SCFAs) are produced by the fermentation of dietary fibers and may influence the gut-brain axis in multiple sclerosis (MS).
- Analysis of plasma and stool samples from a large cohort shows that higher levels of propionate correlate with lower disease activity in MS.
- Findings are validated in a separate large cohort, reinforcing the association between propionate and reduced clinical activity.
- There is a lack of correlation between propionate levels and dietary fiber intake, indicating that dietary changes alone may not effectively alter SCFA levels.
- The results suggest that administering propionate directly could be more beneficial than simply increasing fiber intake in managing MS.
Simplified